Biktarvy, formally known as bictegravir, represents a powerful single-tablet regimen for controlling HIV infection. This drug unites three essential antiviral drugs: bictegravir, emtricitabine, and tenofovir alafenamide. It works by inhibiting the the viral ability to copy within the body, significantly lowering the viral load. For many individua